Dr. Miguel A. Rodriguez

Optometry
Med Southwest PLLC
1929 W State Hwy 46, Suite 103, 
New Braunfels, TX 
Accepting New Patients
Med Southwest PLLC
1929 W State Hwy 46, Suite 103, 
New Braunfels, TX 

Overview

Miguel Rodriguez is an Optometry provider practicing medicine in New Braunfels, Texas.

He is actively involved in clinical research, co-authoring 238 peer reviewed articles and participating in 7 clinical trials. Dr. Rodriguez is currently accepting new patients.

Specialties

Optometry

Licenses

Optometrist in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

MED SOUTHWEST PLLC
1929 W State Hwy 46, Suite 103, New Braunfels, TX 78132

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
View 6 Less Clinical Trials

238 Total Publications

Long-read transcriptomics of purified human cortical cell types exposes glial isoform complexity and disease-relevant transcript architecture.
Long-read transcriptomics of purified human cortical cell types exposes glial isoform complexity and disease-relevant transcript architecture.
Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026
Similar Doctors
Expertise in
0
conditions
Expertise in
0
conditions
Referral may be required
1100 Wilford Hall Loop Bldg 4554, 
Jbsa Lackland, TX 
 (35.3 miles away)
210-292-6255
Languages Spoken:
English
See accepted insurances

Janet Ilidan is an Optometry provider practicing medicine in Jbsa Lackland, Texas. Her clinical expertise encompasses Wagner Syndrome and Ocular Hypertension (OHT).

Expertise in
0
conditions
Expertise in
0
conditions
Referral may be required

Pflugerville Vision Care PA

16303 Yellow Sage St, 
Pflugerville, TX 
 (59.6 miles away)
512-251-4099
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Amie Bethel is an Optometry provider practicing medicine in Pflugerville, Texas. Her clinical expertise encompasses Eyelid Bump. Dr. Bethel is currently accepting new patients.

Expertise in
0
conditions
Expertise in
0
conditions
Referral may be required
4900 Bee Creek Rd, Suite 102, 
Spicewood, TX 
 (43.6 miles away)
325-277-1228
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Roxana Leija is an Optometry provider practicing medicine in Spicewood, Texas. Her clinical expertise encompasses Eyelid Bump. Dr. Leija is currently accepting new patients.

Frequently Asked Questions about Dr. Miguel A. Rodriguez

How do I make an appointment with Dr. Miguel A. Rodriguez?

You can book an appointment with Dr. Miguel A. Rodriguez by calling their office at 830-524-8870. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Does Dr. Miguel A. Rodriguez accept my insurance?

Dr. Miguel A. Rodriguez accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 830-524-8870 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rodriguez's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile